T2* relaxation time in the detection and assessment of aggressiveness of peripheral zone cancer in comparison with diffusion-weighted imaging.

AIM - To investigate the feasibility of T2* relaxation time for distinguishing benign from malignant regions, as well as tumour aggressiveness, within the peripheral zone (PZ) of the prostate in comparison with diffusion-weighted imaging (DWI).

MATERIALS AND METHODS - Fifty-eight patients with prostate cancer underwent 3 T magnetic resonance imaging using multi-echo T2* and DWI (maximum b-value, 2000 s/mm(2)). Parametric maps were obtained for apparent diffusion coefficient (ADC) and T2* values. Two radiologists reviewed these maps and measured ADC and T2* values in sextants positive for cancer at biopsy. Data were analysed using mixed-model analysis of variance and receiver operating characteristic curves.

RESULTS - Ninety-three sextants exhibited a Gleason score of 6; 59 exhibited a Gleason score of 7 or 8. The T2* value was significantly lower in cancerous sextants than in the benign PZ (48. 69+0. 60 versus 74. 14+0. 56, p<0. 001), as well as in cancerous sextants with higher rather than lower Gleason scores (43. 18+0. 89 versus 52. 18+0. 55, p<0. 001). The T2* value showed significantly greater specificity for differentiating cancerous sextants from benign PZ than ADC (93. 1% versus 89. 7%, p<0. 001), with equal sensitivity (82. 8% versus 81%, p>0. 05). The T2* value exhibited significantly greater sensitivity and specificity for differentiating sextants with low- and high-grade cancer than ADC (79. 6% versus 64. 5% and 81. 4% versus 72. 9%, respectively; p<0. 05). The T2* value had a significantly greater area under the receiver operating characteristic curve for differentiating sextants with low- and high-grade cancer than ADC (0. 77 versus 0. 71, p<0. 01).

CONCLUSIONS - Preliminary findings suggest that the T2* relaxation time has increased diagnostic value compared with DWI in prostate PZ cancer assessment.

Clinical radiology. 2016 Jan 25 [Epub ahead of print]

L-M Wu, B Zhou, Q Lu, S-T Suo, Q Liu, J Hu, E M Haccke, X-X Chen, J-R Xu

Department of Radiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China. , Department of Radiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China. , Department of Radiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China. , Department of Radiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China. , Department of Pathology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China. , Department of Radiology, Wayne State University, Detroit, MI 48201, USA. , Department of Radiology, Wayne State University, Detroit, MI 48201, USA. , Department of Radiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China. , Department of Radiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China. 

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe